News tagged with drug prices
More than 100 doctors from around the world have signed a letter decrying the high cost of cancer drugs which reach $100,000 per year or more, and calling for pharmaceutical companies to ease prices.
Medications Apr 26, 2013 | 5 / 5 (4) | 2
U.S. health regulators will require generic versions of the best-selling painkiller OxyContin to include recent formulation changes designed to make the pill harder to abuse.
Medications Apr 16, 2013 | not rated yet | 1
US scientists on Wednesday said they had used baker's yeast to make a key ingredient of malaria drugs, a feat that could iron out fluctuations in supply caused by sourcing the chemical from a Chinese herb.
Diseases, Conditions, Syndromes Apr 10, 2013 | 5 / 5 (1) | 0
(HealthDay News) —Prescription drug prices at U.S. pharmacies can vary widely, and failing to shop around could result in people overpaying by as much as $100 or more a month on average, depending on the ...
Medications Mar 28, 2013 | not rated yet | 0
The commitment of Canadian premiers to lower generic drug prices is a major change in how the country prices generic drugs, and government should learn from past attempts, states an article published in CMAJ (Canadian Medical A ...
Medications Nov 19, 2012 | 5 / 5 (1) | 0
(AP)—The Federal Trade Commission says it is mailing refund checks to 13,000 Medicare beneficiaries who were overcharged for drugs because a CVS Caremark Corp. business understated the price of the products.
Medications Sep 04, 2012 | not rated yet | 0
The public oppose the cancer drugs fund but support the new pricing system for branded medicines, according to a new study.
Medications Aug 16, 2012 | not rated yet | 0
(HealthDay) -- Even in the field of cancer treatment, sometimes newer isn't necessarily better.
Cancer Jun 04, 2012 | not rated yet | 0 |
Pfizer's patent on the best-selling drug of all-time, the cholesterol-lowering medication Lipitor, expired on Wednesday, opening the path to generic competitors for America's most popular medication.
Medications Nov 30, 2011 | not rated yet | 1
Prior knowledge of phase III clinical trials of new drugs and Food and Drug Administration (FDA) regulatory decisions may affect the price of a drug company's stock according to a study published September 26 in the Journal of ...
Other Sep 26, 2011 | not rated yet | 0